Flualprazolam is a synthetic depressant that is structurally related to benzodiazepines. Flualprazolam has been shown to inhibit the growth of cancer cells in culture and in mice. The drug is excreted primarily through the kidneys as unchanged drug, but also as metabolites. Flualprazolam can be detected in urine by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) methods.

Flualprazolam has clinical properties similar to other benzodiazepines, which include sedation, hypnotic effects, muscle relaxation, and anticonvulsant activity. This drug also has been shown to have some anti-inflammatory effects against experimental models of inflammatory diseases such as arthritis and colitis.